申请人:Merck & Co., Inc.
公开号:US04144345A1
公开(公告)日:1979-03-13
Dihydroxybenzisoxazolin-3-yl-substituted-1-methyl-5-nitroimidazoles having the hydroxy- groups on adjacent 4,5-; 5,6- or 6,7-positions of the isoxazolin group. These compounds have antibacterial and antiprotozoal activity in humans and animals. They are particularly active against trypanosomiasis and trichomoniasis.
二羟基苯并异噁唑啉-3-基取代的1-甲基-5-硝基咪唑,其氢氧基团位于异噁唑啉基团相邻的4,5-;5,6-或6,7-位置。这些化合物在人类和动物中具有抗菌和抗原虫活性。它们对锥虫病和滴虫病特别有效。